Literature DB >> 22083068

CCR5 expression is elevated on endocervical CD4+ T cells in healthy postmenopausal women.

Amie L Meditz1, Kerrie L Moreau, Samantha MaWhinney, Wendolyn S Gozansky, Kelsey Melander, Wendy M Kohrt, Margaret E Wierman, Elizabeth Connick.   

Abstract

BACKGROUND: New HIV-1 infections are increasing in older American women largely through heterosexual transmission. Activated CD4+ T cells and CCR5 expression are linked to HIV-1 susceptibility, but whether these parameters are altered in the cervix of older women is unknown.
METHODS: Whole blood and in some instances endocervical brush samples were collected from healthy premenopausal (n = 22) and postmenopausal women (n = 24). Percentages of HLA-DR(DR)+CD38(38)+CD4+ T cells and HIV-1 chemokine coreceptor expression were determined by flow cytometry.
RESULTS: Percentages of DR+38+CD4+ T cells were 6 times greater in cervix (median: 6.4%) than blood (median: 1.1%; P < 0.001) but did not differ within each compartment between premenopausal and postmenopausal women (P = 0.2). Postmenopausal women had greater percentages of CCR5+CD4+ and CCR5+DR+38+CD4+ T cells compared with premenopausal women in cervix (median: 70% vs. 42%, P = 0.005; and 80% vs. 57%; P = 0.05, respectively) and blood (medians: 22% vs. 13%, and 76% vs. 62%, respectively; P < 0.001). Postmenopausal women had more CCR5 molecules on cervical DR+38+CD4+ T cells (median: 3176) than premenopausal women (median: 1776; P = 0.02). Age and percent CCR5+CD4+ and CCR5+DR+38+CD4+ cells were linearly related in cervix (r(2) = 0.47, P < 0.001 and r(2) = 0.25, P = 0.01, respectively) and blood (r(2) = 0.20, P = 0.001 and r(2) = 0.31, P < 0.001; respectively), but confounding of age with menopause could not be excluded. Cervical CXCR4 expression did not differ substantially between premenopausal and postmenopausal women.
CONCLUSIONS: Elevated cervical CCR5 expression in postmenopausal women may increase their risk for HIV-1 acquisition. Studies are needed to confirm whether elevated CCR5 expression confers increased HIV-1 susceptibility in postmenopausal women, and if it is related to hormonal or nonhormonal effects of aging.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22083068      PMCID: PMC3288615          DOI: 10.1097/QAI.0b013e31823fd215

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  45 in total

1.  Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract. WHS 001 Study Team.

Authors:  P S Reichelderfer; R W Coombs; D J Wright; J Cohn; D N Burns; S Cu-Uvin; P A Baron; M H Coheng; A L Landay; S K Beckner; S R Lewis; A A Kovacs
Journal:  AIDS       Date:  2000-09-29       Impact factor: 4.177

Review 2.  Host determinants in HIV infection and disease. Part 2: genetic factors and implications for antiretroviral therapeutics.

Authors:  C M Hogan; S M Hammer
Journal:  Ann Intern Med       Date:  2001-05-15       Impact factor: 25.391

3.  Enhanced HIV-1 replication in ex vivo ectocervical tissues from post-menopausal women correlates with increased inflammatory responses.

Authors:  C Rollenhagen; S N Asin
Journal:  Mucosal Immunol       Date:  2011-08-31       Impact factor: 7.313

Review 4.  Aging and proinflammatory cytokines.

Authors:  H Bruunsgaard; M Pedersen; B K Pedersen
Journal:  Curr Opin Hematol       Date:  2001-05       Impact factor: 3.284

5.  Human immunodeficiency virus Type 1 (HIV-1) plasma virus load and markers of immune activation among HIV-infected female sex workers with sexually transmitted diseases in Abidjan, Côte d'Ivoire.

Authors:  J N Nkengasong; L Kestens; P D Ghys; S Koblavi-Dème; C Bilé; M Kalou; L K Ya; V Traoré-Ettiègne; C Maurice; M Laga; S Z Wiktor; A E Greenberg
Journal:  J Infect Dis       Date:  2001-03-16       Impact factor: 5.226

6.  Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells.

Authors:  Z Zhang; T Schuler; M Zupancic; S Wietgrefe; K A Staskus; K A Reimann; T A Reinhart; M Rogan; W Cavert; C J Miller; R S Veazey; D Notermans; S Little; S A Danner; D D Richman; D Havlir; J Wong; H L Jordan; T W Schacker; P Racz; K Tenner-Racz; N L Letvin; S Wolinsky; A T Haase
Journal:  Science       Date:  1999-11-12       Impact factor: 47.728

7.  Estrogen protects against vaginal transmission of simian immunodeficiency virus.

Authors:  S M Smith; G B Baskin; P A Marx
Journal:  J Infect Dis       Date:  2000-08-08       Impact factor: 5.226

8.  CD4 T cell surface CCR5 density as a host factor in HIV-1 disease progression.

Authors:  J Reynes; P Portales; M Segondy; V Baillat; P André; O Avinens; M C Picot; J Clot; J F Eliaou; P Corbeau
Journal:  AIDS       Date:  2001-09-07       Impact factor: 4.177

9.  Homozygous and heterozygous CCR5-Delta32 genotypes are associated with resistance to HIV infection.

Authors:  M Marmor; H W Sheppard; D Donnell; S Bozeman; C Celum; S Buchbinder; B Koblin; G R Seage
Journal:  J Acquir Immune Defic Syndr       Date:  2001-08-15       Impact factor: 3.731

10.  Higher levels of activation markers and chemokine receptors on T lymphocytes in the cervix than peripheral blood of normal healthy women.

Authors:  M Prakash; M S Kapembwa; F Gotch; S Patterson
Journal:  J Reprod Immunol       Date:  2001 Oct-Nov       Impact factor: 4.054

View more
  32 in total

1.  CCR5 expression is reduced in lymph nodes of HIV type 1-infected women, compared with men, but does not mediate sex-based differences in viral loads.

Authors:  Amie L Meditz; Joy M Folkvord; Ngan H Lyle; Kristina Searls; Yolanda S Lie; Eoin P Coakley; Martin McCarter; Samantha Mawhinney; Elizabeth Connick
Journal:  J Infect Dis       Date:  2013-10-31       Impact factor: 5.226

Review 2.  Innate and adaptive anti-HIV immune responses in the female reproductive tract.

Authors:  Marta Rodriguez-Garcia; Mickey V Patel; Charles R Wira
Journal:  J Reprod Immunol       Date:  2013-03       Impact factor: 4.054

3.  Identification of preferential CD4+ T-cell targets for HIV infection in the cervix.

Authors:  V R Joag; L R McKinnon; J Liu; S T Kidane; M H Yudin; B Nyanga; S Kimwaki; K E Besel; J O Obila; S Huibner; J O Oyugi; J Arthos; O Anzala; J Kimani; M A Ostrowski; R Kaul
Journal:  Mucosal Immunol       Date:  2015-04-15       Impact factor: 7.313

4.  The effect of menopause on the innate antiviral activity of cervicovaginal lavage.

Authors:  Catherine A Chappell; Charles E Isaacs; Weimin Xu; Leslie A Meyn; Kevin Uranker; Charlene S Dezzutti; Bernard J Moncla; Sharon L Hillier
Journal:  Am J Obstet Gynecol       Date:  2015-03-25       Impact factor: 8.661

5.  A Summary of the Fourth Annual Virology Education HIV Microbiome Workshop.

Authors:  Brett Williams; Mimi Ghosh; Charles Boucher; Frederic Bushman; Stacy Carrington-Lawrence; Ronald G Collman; Satya Dandekar; Que Dang; Angela Malaspina; Roger Paredes; Cara Wilson; Sandra Pinto Cardoso; Laurel Lagenaur; Jessica Santos; Christopher Joy; Alan Landay
Journal:  AIDS Res Hum Retroviruses       Date:  2020-03-09       Impact factor: 2.205

Review 6.  Immunobiology of genital tract trauma: endocrine regulation of HIV acquisition in women following sexual assault or genital tract mutilation.

Authors:  Mimi Ghosh; Marta Rodriguez-Garcia; Charles R Wira
Journal:  Am J Reprod Immunol       Date:  2012-10-04       Impact factor: 3.886

Review 7.  The immune system in menopause: pros and cons of hormone therapy.

Authors:  Mimi Ghosh; Marta Rodriguez-Garcia; Charles R Wira
Journal:  J Steroid Biochem Mol Biol       Date:  2013-09-13       Impact factor: 4.292

8.  Phase 2a Safety, Pharmacokinetics, and Acceptability of Dapivirine Vaginal Rings in US Postmenopausal Women.

Authors:  Beatrice A Chen; Jingyang Zhang; Holly M Gundacker; Craig W Hendrix; Craig J Hoesley; Robert A Salata; Charlene S Dezzutti; Ariane van der Straten; Wayne B Hall; Cindy E Jacobson; Sherri Johnson; Ian McGowan; Annalene M Nel; Lydia Soto-Torres; Mark A Marzinke
Journal:  Clin Infect Dis       Date:  2019-03-19       Impact factor: 9.079

Review 9.  Sex-based differences in HIV type 1 pathogenesis.

Authors:  Marylyn M Addo; Marcus Altfeld
Journal:  J Infect Dis       Date:  2014-07-15       Impact factor: 5.226

Review 10.  Research gaps in defining the biological link between HIV risk and hormonal contraception.

Authors:  Kerry Murphy; Susan C Irvin; Betsy C Herold
Journal:  Am J Reprod Immunol       Date:  2014-02-19       Impact factor: 3.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.